Advertisement

Index by author

March 01, 1996; Volume 49,Issue 3

A

  1. Agrawal, A K

    1. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose.
      A K Agrawal and B H Shapiro
      Molecular Pharmacology March 1996, 49 (3) 523-531;

  2. Ahern, S

    1. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
      L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
      Molecular Pharmacology March 1996, 49 (3) 422-429;

  3. Arinami, T

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

B

  1. Banerjee, D

    1. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
      E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
      Molecular Pharmacology March 1996, 49 (3) 430-437;

  2. Barrie, A

    1. Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes.
      A Barrie, E Chieregatti, M Miloso, F Benfenati and F Valtorta
      Molecular Pharmacology March 1996, 49 (3) 399-403;

  3. Benfenati, F

    1. Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes.
      A Barrie, E Chieregatti, M Miloso, F Benfenati and F Valtorta
      Molecular Pharmacology March 1996, 49 (3) 399-403;

  4. Bertino, J R

    1. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
      E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
      Molecular Pharmacology March 1996, 49 (3) 430-437;

  5. Bockaert, J

    1. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
      L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
      Molecular Pharmacology March 1996, 49 (3) 422-429;

  6. Bunnett, N W

    1. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
      A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
      Molecular Pharmacology March 1996, 49 (3) 438-446;

C

  1. Chieregatti, E

    1. Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes.
      A Barrie, E Chieregatti, M Miloso, F Benfenati and F Valtorta
      Molecular Pharmacology March 1996, 49 (3) 399-403;

  2. Colby, H D

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

  3. Contesse, V

    1. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
      V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue
      Molecular Pharmacology March 1996, 49 (3) 481-493;

  4. Coon, M J

    1. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
      G M Raner, A D Vaz and M J Coon
      Molecular Pharmacology March 1996, 49 (3) 515-522;

  5. Coyle, A J

    1. Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
      L A Dowd, A J Coyle, J D Rothstein, D B Pritchett and M B Robinson
      Molecular Pharmacology March 1996, 49 (3) 465-473;

D

  1. De Angelis, I

    1. N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
      L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
      Molecular Pharmacology March 1996, 49 (3) 547-555;

  2. DeBolt, B K

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

  3. Delarue, C

    1. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
      V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue
      Molecular Pharmacology March 1996, 49 (3) 481-493;

  4. Dicker, A P

    1. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
      E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
      Molecular Pharmacology March 1996, 49 (3) 430-437;

  5. Dowd, L A

    1. Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
      L A Dowd, A J Coyle, J D Rothstein, D B Pritchett and M B Robinson
      Molecular Pharmacology March 1996, 49 (3) 465-473;

  6. Dubru, F

    1. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
      S Mankhetkorn, F Dubru, J Hesschenbrouck, M Fiallo and A Garnier-Suillerot
      Molecular Pharmacology March 1996, 49 (3) 532-539;

  7. Dumuis, A

    1. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
      V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue
      Molecular Pharmacology March 1996, 49 (3) 481-493;

E

  1. Ercikan-Abali, E A

    1. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
      E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
      Molecular Pharmacology March 1996, 49 (3) 430-437;

F

  1. Feldman, R I

    1. Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
      R I Feldman, S Fried, E Mann, J M Wu and M Liang
      Molecular Pharmacology March 1996, 49 (3) 505-514;

  2. Fiallo, M

    1. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
      S Mankhetkorn, F Dubru, J Hesschenbrouck, M Fiallo and A Garnier-Suillerot
      Molecular Pharmacology March 1996, 49 (3) 532-539;

  3. Fried, S

    1. Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
      R I Feldman, S Fried, E Mann, J M Wu and M Liang
      Molecular Pharmacology March 1996, 49 (3) 505-514;

  4. Frucht, M M

    1. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
      A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
      Molecular Pharmacology March 1996, 49 (3) 438-446;

  5. Funae, Y

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

G

  1. Galvez, T

    1. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
      L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
      Molecular Pharmacology March 1996, 49 (3) 422-429;

  2. Garland, A M

    1. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
      A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
      Molecular Pharmacology March 1996, 49 (3) 438-446;

  3. Garnier-Suillerot, A

    1. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
      S Mankhetkorn, F Dubru, J Hesschenbrouck, M Fiallo and A Garnier-Suillerot
      Molecular Pharmacology March 1996, 49 (3) 532-539;

  4. Gobbi, M

    1. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
      M Gobbi, L Parotti and T Mennini
      Molecular Pharmacology March 1996, 49 (3) 556-559;

  5. Gomeza, J

    1. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
      L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
      Molecular Pharmacology March 1996, 49 (3) 422-429;

  6. Grady, E F

    1. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
      A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
      Molecular Pharmacology March 1996, 49 (3) 438-446;

  7. Gritsman, H

    1. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
      E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
      Molecular Pharmacology March 1996, 49 (3) 430-437;

H

  1. Haga, T

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

  2. Hamaguchi, H

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

  3. Hamel, C

    1. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
      V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue
      Molecular Pharmacology March 1996, 49 (3) 481-493;

  4. Hesschenbrouck, J

    1. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
      S Mankhetkorn, F Dubru, J Hesschenbrouck, M Fiallo and A Garnier-Suillerot
      Molecular Pharmacology March 1996, 49 (3) 532-539;

  5. Huang, Y

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

  6. Huettner, J E

    1. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
      T J Wilding and J E Huettner
      Molecular Pharmacology March 1996, 49 (3) 540-546;

  7. Humbert, Y

    1. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
      J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North
      Molecular Pharmacology March 1996, 49 (3) 387-390;

I

  1. Ito, K

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

  2. Itokawa, M

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

J

  1. Jiang, Q

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

K

  1. Kameyama, K

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

  2. Katsura, Y

    1. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
      F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
      Molecular Pharmacology March 1996, 49 (3) 447-457;

  3. Kominami, S

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

  4. Krause, J E

    1. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
      A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
      Molecular Pharmacology March 1996, 49 (3) 438-446;

  5. Krishek, B J

    1. Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
      B J Krishek, S J Moss and T G Smart
      Molecular Pharmacology March 1996, 49 (3) 494-504;

  6. Kuppusamy, P

    1. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. I. Chemical reactions involved in the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweier and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 404-411;
    2. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweir and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 412-421;

L

  1. Lefebvre, H

    1. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
      V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue
      Molecular Pharmacology March 1996, 49 (3) 481-493;

  2. Li, Y

    1. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. I. Chemical reactions involved in the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweier and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 404-411;
    2. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweir and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 412-421;

  3. Liang, M

    1. Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
      R I Feldman, S Fried, E Mann, J M Wu and M Liang
      Molecular Pharmacology March 1996, 49 (3) 505-514;

  4. Lovett, M

    1. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
      A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
      Molecular Pharmacology March 1996, 49 (3) 438-446;

M

  1. Macdonald, R L

    1. Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms.
      N C Saxena and R L Macdonald
      Molecular Pharmacology March 1996, 49 (3) 567-579;

  2. Mankhetkorn, S

    1. Relation among the resistance factor, kinetics of uptake, and kinetics of the P-glycoprotein-mediated efflux of doxorubicin, daunorubicin, 8-(S)-fluoroidarubicin, and idarubicin in multidrug-resistant K562 cells.
      S Mankhetkorn, F Dubru, J Hesschenbrouck, M Fiallo and A Garnier-Suillerot
      Molecular Pharmacology March 1996, 49 (3) 532-539;

  3. Mann, E

    1. Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
      R I Feldman, S Fried, E Mann, J M Wu and M Liang
      Molecular Pharmacology March 1996, 49 (3) 505-514;

  4. Marchese, E

    1. N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
      L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
      Molecular Pharmacology March 1996, 49 (3) 547-555;

  5. Mary, S

    1. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
      L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
      Molecular Pharmacology March 1996, 49 (3) 422-429;

  6. Masaki, T

    1. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
      F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
      Molecular Pharmacology March 1996, 49 (3) 447-457;

  7. Mazda, O

    1. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
      F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
      Molecular Pharmacology March 1996, 49 (3) 447-457;

  8. Mennini, T

    1. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
      M Gobbi, L Parotti and T Mennini
      Molecular Pharmacology March 1996, 49 (3) 556-559;

  9. Miloso, M

    1. Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes.
      A Barrie, E Chieregatti, M Miloso, F Benfenati and F Valtorta
      Molecular Pharmacology March 1996, 49 (3) 399-403;

  10. Miwa, S

    1. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
      F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
      Molecular Pharmacology March 1996, 49 (3) 447-457;

  11. Moss, S J

    1. Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
      B J Krishek, S J Moss and T G Smart
      Molecular Pharmacology March 1996, 49 (3) 494-504;

N

  1. Ninomiya, H

    1. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
      F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
      Molecular Pharmacology March 1996, 49 (3) 447-457;

  2. North, R A

    1. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
      J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North
      Molecular Pharmacology March 1996, 49 (3) 387-390;

O

  1. Okamoto, Y

    1. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
      F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
      Molecular Pharmacology March 1996, 49 (3) 447-457;

P

  1. Parotti, L

    1. Are 5-hydroxytryptamine7 receptors involved in [3H]5-hydroxytryptamine binding to 5-hydroxytryptamine 1nonA-nonB receptors in rat hypothalamus?
      M Gobbi, L Parotti and T Mennini
      Molecular Pharmacology March 1996, 49 (3) 556-559;

  2. Pedersen, J Z

    1. N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
      L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
      Molecular Pharmacology March 1996, 49 (3) 547-555;

  3. Pin, J P

    1. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
      L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
      Molecular Pharmacology March 1996, 49 (3) 422-429;

  4. Pollenz, R S

    1. The aryl-hydrocarbon receptor, but not the aryl-hydrocarbon receptor nuclear translocator protein, is rapidly depleted in hepatic and nonhepatic culture cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.
      R S Pollenz
      Molecular Pharmacology March 1996, 49 (3) 391-398;

  5. Prézeau, L

    1. Changes in the carboxyl-terminal domain of metabotropic glutamate receptor 1 by alternative splicing generate receptors with differing agonist-independent activity.
      L Prézeau, J Gomeza, S Ahern, S Mary, T Galvez, J Bockaert and J P Pin
      Molecular Pharmacology March 1996, 49 (3) 422-429;

  6. Pritchett, D B

    1. Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
      L A Dowd, A J Coyle, J D Rothstein, D B Pritchett and M B Robinson
      Molecular Pharmacology March 1996, 49 (3) 465-473;

R

  1. Raner, G M

    1. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
      G M Raner, A D Vaz and M J Coon
      Molecular Pharmacology March 1996, 49 (3) 515-522;

  2. Ratti, E

    1. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
      J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North
      Molecular Pharmacology March 1996, 49 (3) 387-390;

  3. Rimland, J M

    1. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
      J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North
      Molecular Pharmacology March 1996, 49 (3) 387-390;

  4. Robinson, M B

    1. Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
      L A Dowd, A J Coyle, J D Rothstein, D B Pritchett and M B Robinson
      Molecular Pharmacology March 1996, 49 (3) 465-473;

  5. Rossi, L

    1. N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
      L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
      Molecular Pharmacology March 1996, 49 (3) 547-555;

  6. Rothstein, J D

    1. Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).
      L A Dowd, A J Coyle, J D Rothstein, D B Pritchett and M B Robinson
      Molecular Pharmacology March 1996, 49 (3) 465-473;

  7. Rotilio, G

    1. N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
      L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
      Molecular Pharmacology March 1996, 49 (3) 547-555;

S

  1. Sanders-Bush, E

    1. Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
      R S Westphal and E Sanders-Bush
      Molecular Pharmacology March 1996, 49 (3) 474-480;

  2. Saxena, N C

    1. Properties of putative cerebellar gamma-aminobutyric acid A receptor isoforms.
      N C Saxena and R L Macdonald
      Molecular Pharmacology March 1996, 49 (3) 567-579;

  3. Schweitzer, B I

    1. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
      E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
      Molecular Pharmacology March 1996, 49 (3) 430-437;

  4. Seward, E P

    1. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
      J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North
      Molecular Pharmacology March 1996, 49 (3) 387-390;

  5. Shapiro, B H

    1. Phenobarbital induction of hepatic CYP2B1 and CYP2B2: pretranscriptional and post-transcriptional effects of gender, adult age, and phenobarbital dose.
      A K Agrawal and B H Shapiro
      Molecular Pharmacology March 1996, 49 (3) 523-531;

  6. Smart, T G

    1. Homomeric beta 1 gamma-aminobutyric acid A receptor-ion channels: evaluation of pharmacological and physiological properties.
      B J Krishek, S J Moss and T G Smart
      Molecular Pharmacology March 1996, 49 (3) 494-504;

  7. Stammati, A

    1. N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
      L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
      Molecular Pharmacology March 1996, 49 (3) 547-555;

  8. Sugawara, F

    1. Endothelin-1-induced mitogenic responses of Chinese hamster ovary cells expressing human endothelinA: the role of a wortmannin-sensitive signaling pathway.
      F Sugawara, H Ninomiya, Y Okamoto, S Miwa, O Mazda, Y Katsura and T Masaki
      Molecular Pharmacology March 1996, 49 (3) 447-457;

T

  1. Takemori, S

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

  2. Toru, M

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

  3. Trist, D G

    1. Coexpression with potassium channel subunits used to clone the Y2 receptor for neuropeptide Y.
      J M Rimland, E P Seward, Y Humbert, E Ratti, D G Trist and R A North
      Molecular Pharmacology March 1996, 49 (3) 387-390;

  4. Trush, M A

    1. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. I. Chemical reactions involved in the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweier and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 404-411;
    2. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweir and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 412-421;

  5. Tsuga, H

    1. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
      M Itokawa, M Toru, K Ito, H Tsuga, K Kameyama, T Haga, T Arinami and H Hamaguchi
      Molecular Pharmacology March 1996, 49 (3) 560-566;

V

  1. Valtorta, F

    1. Epidermal growth factor-mediated inhibition of neurotransmitter glutamate release from rat forebrain synaptosomes.
      A Barrie, E Chieregatti, M Miloso, F Benfenati and F Valtorta
      Molecular Pharmacology March 1996, 49 (3) 399-403;

  2. Vaudry, H

    1. Activation of 5-hydroxytryptamine4 receptors causes calcium influx in adrenocortical cells: involvement of calcium in 5-hydroxytryptamine-induced steroid secretion.
      V Contesse, C Hamel, H Lefebvre, A Dumuis, H Vaudry and C Delarue
      Molecular Pharmacology March 1996, 49 (3) 481-493;

  3. Vaz, A D

    1. Metabolism of all-trans, 9-cis, and 13-cis isomers of retinal by purified isozymes of microsomal cytochrome P450 and mechanism-based inhibition of retinoid oxidation by citral.
      G M Raner, A D Vaz and M J Coon
      Molecular Pharmacology March 1996, 49 (3) 515-522;

  4. Vigna, S R

    1. Mechanisms of desensitization and resensitization of G protein-coupled neurokinin1 and neurokinin2 receptors.
      A M Garland, E F Grady, M Lovett, S R Vigna, M M Frucht, J E Krause and N W Bunnett
      Molecular Pharmacology March 1996, 49 (3) 438-446;

  5. Voigt, J M

    1. Expression and zonal distribution of CYP2D16 in the guinea pig adrenal cortex: relationship to xenobiotic metabolism.
      Q Jiang, Y Huang, J M Voigt, B K DeBolt, S Kominami, S Takemori, Y Funae and H D Colby
      Molecular Pharmacology March 1996, 49 (3) 458-464;

W

  1. Waltham, M C

    1. Variants of human dihydrofolate reductase with substitutions at leucine-22: effect on catalytic and inhibitor binding properties.
      E A Ercikan-Abali, M C Waltham, A P Dicker, B I Schweitzer, H Gritsman, D Banerjee and J R Bertino
      Molecular Pharmacology March 1996, 49 (3) 430-437;

  2. Westphal, R S

    1. Differences in agonist-independent and -dependent 5-hydroxytryptamine2C receptor-mediated cell division.
      R S Westphal and E Sanders-Bush
      Molecular Pharmacology March 1996, 49 (3) 474-480;

  3. Wilding, T J

    1. Antagonist pharmacology of kainate- and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid-preferring receptors.
      T J Wilding and J E Huettner
      Molecular Pharmacology March 1996, 49 (3) 540-546;

  4. Wu, J M

    1. Gastrin-releasing peptide receptor signaling resulting in growth inhibition.
      R I Feldman, S Fried, E Mann, J M Wu and M Liang
      Molecular Pharmacology March 1996, 49 (3) 505-514;

Z

  1. Zucco, F

    1. N-[5-nitro-2-furfurylidene]-3-amino-2-oxazolidinone activation by the human intestinal cell line Caco-2 monitored through noninvasive electron spin resonance spectroscopy.
      L Rossi, I De Angelis, J Z Pedersen, E Marchese, A Stammati, G Rotilio and F Zucco
      Molecular Pharmacology March 1996, 49 (3) 547-555;

  2. Zweier, J L

    1. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. I. Chemical reactions involved in the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweier and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 404-411;

  3. Zweir, J L

    1. Role of Cu/Zn-superoxide dismutase in xenobiotic activation. II. Biological effects resulting from the Cu/Zn-superoxide dismutase-accelerated oxidation of the benzene metabolite 1,4-hydroquinone.
      Y Li, P Kuppusamy, J L Zweir and M A Trush
      Molecular Pharmacology March 1996, 49 (3) 412-421;
Back to top

In this issue

Advertisement